Dictionary

allow_url_fopen is ENABLED Dictionary Search

dyskinesia

Synonyms

Noun

1. nervous disorder

2. neurological disorder, neurological disease

Usage
Measuring Tardive Dyskinesia Symptoms With the AIMS - MedPage Today
Early Recognition and Routine Discussion: Improving Outcomes in Tardive Dyskinesia - Pharmacy Times – Pharmacy Practice News and Expert Insights
Clinical Reasoning: A Woman With Parkinson Disease, Dyskinesia, Rhabdomyolysis, Subcutaneous Emphysema, and Pneumomediastinum - Neurology® Journals
Neurocrine (NBIX) Reports Clinically Meaningful Benefits in 94% of Patients Treated for Tardive Dyskinesia - Yahoo Finance
Neurocrine Biosciences Announces New Survey Results Showing Significant Burden of Tardive Dyskinesia on Employment - PR Newswire
Living with Tardive Dyskinesia - Brain & Life
Tardive Dyskinesia: Implications in Mental Health Conditions - Medscape
Diagnostic Challenges in Distinguishing Huntington Disease From Tardive Dyskinesia - Psychiatrist.com
Association between wearable-derived dyskinesia time burden and longitudinal change in disability in people with Parkinson’s disease: a real-world treat-to-target cohort study | Scientific Reports - Nature
Gene therapy strategy may ease Parkinson’s disease dyskinesia - Parkinson's News Today
Levodopa-induced dyskinesia in Parkinson’s disease: an updated review of pharmacological treatments - Frontiers
CMS Moves to Close the Tardive Dyskinesia Screening Gap - Pharmacy Practice News
How Genetic Mutations Cause Primary Ciliary Dyskinesia - respiratory-therapy.com
First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings - Psychiatric Times
Phase 3 Post Hoc Analysis Shows Foslevodopa/Foscarbidopa Reduces Troublesome Dyskinesia in Advanced Parkinson Disease - NeurologyLive
Tardive Dyskinesia Uncovered: Raising Awareness of a Chronic, Irreversible Condition - Pharmacy Times – Pharmacy Practice News and Expert Insights
Neurocrine Biosciences Presents New Data Highlighting Functional and Socio-emotional Improvements with INGREZZA® (valbenazine) Capsules in Individuals with Tardive Dyskinesia and Intellectual and Developmental Disabilities - PR Newswire
The Patient Perspective on Tardive Dyskinesia - Psychiatrist.com
Neurocrine Biosciences Presents New Clinically Meaningful Response Data on Treatment of Tardive Dyskinesia, Reinforcing the Efficacy of INGREZZA® (valbenazine) Capsules Across a Broad Range of Patients - PR Newswire
Measuring What Matters: Further Validation for the Tardive Dyskinesia Impact Scale, a Novel Patient-Reported Outcome Measure in Valbenazine Clinical Trials - Psychiatrist.com
Immunis plans Phase 1 trial of treatment for Parkinson’s dyskinesia - Parkinson's News Today
Tardive Dyskinesia in Older Adults: Identification and Management in Long-Term Care Settings - Psychiatric Times
AAN 2026: Switch to Vyalev stops troublesome dyskinesia in trial - Parkinson's News Today
Musician Carnie Wilson Talks Tardive Dyskinesia (TD): Signs, Stigma, and Getting Diagnosed - FOX Carolina News
Neurocrine Biosciences Presents Real-World Data Highlighting Functional Impact of Mild Tardive Dyskinesia Severity and Improvement with INGREZZA® (valbenazine) Capsules - PR Newswire
Tardive Dyskinesia in Children and Adolescents: Uncommon, but Not Absent - Pharmacy Practice News
Managing Tardive Dyskinesia (Part 6) - Specialty Pharmacy Continuum
State-dependent modulation of spiny projection neurons controls levodopa-induced dyskinesia in a mouse model of Parkinson’s disease - Science | AAAS
Medicare Policy Expansion: Implications for Patients With Tardive Dyskinesia - Clinical Advisor
AI Screening Tool for Tardive Dyskinesia Identifies Disorder and Prompts Clinical Evaluation - Psychiatric Times
Loss-of-function variants in ODAD1 disrupt ODA docking and induce actin cytoskeletal remodeling in primary ciliary dyskinesia - Nature
Managing Tardive Dyskinesia: Drug-Induced Risks and Therapeutic Advances - Specialty Pharmacy Continuum
Masking and Unmasking in Tardive Dyskinesia - Pharmacy Practice News
Hidden Inflammation in Primary Ciliary Dyskinesia - respiratory-therapy.com
First Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings - Pharmacy Practice News
Managing Tardive Dyskinesia (Part 2) - Specialty Pharmacy Continuum
Risk of Tardive Dyskinesia Higher in Women - MedPage Today
Patients With Tardive Dyskinesia Symptoms May Go Undiagnosed - MedPage Today
New Data From IMPACT-TD Registry: Only 23% of Young Adults With Mood Disorders and Tardive Dyskinesia Symptoms Are Formally Diagnosed - Psychiatric Times
Spotlight on the Psychosocial Impact of Tardive Dyskinesia - Psychiatry Advisor
Ask the Advocate: How Can I Cope with the Stigma of Tardive Dyskinesia? - Healthline
Distinguishing Tardive Dyskinesia From Other Drug-Induced Movement Disorders - Pharmacy Practice News
Tardive Dyskinesia Why Mild Cases Are Hardest To Manage - Pharmacy Practice News
Experts develop treatment recommendations for tardive dyskinesia among nursing home residents - McKnight's Long-Term Care News
Building a Tardive Dyskinesia Center of Excellence: A Multidisciplinary Model - Pharmacy Practice News
Resources for Hispanic and Latino People with Tardive Dyskinesia - Healthgrades
Functional movement disorder mimicking oromandibular dyskinesia - Springer Nature Link
Pharmacists Can Help Close The Tardive Dyskinesia Dx Gap - Pharmacy Practice News
Risk Factors of Tardive Dyskinesia - Pharmacy Times – Pharmacy Practice News and Expert Insights
Phase 4 Data Support Effectiveness of Deutetrabenazine in Managing Tardive Dyskinesia, Chorea - NeurologyLive
Immunis Licenses Treatment Candidate for Dyskinesia Associated with Parkinson’s Disease - Business Wire
ReCode Therapeutics Achieves a First: Proof of Activity in Primary Ciliary Dyskinesia Patients - Business Wire
New Review on VMAT2 Inhibitors and Ingrezza for Treatment of Tardive Dyskinesia - Psychiatric Times
Most Tardive Dyskinesia Cases Go Undiagnosed, Real-World Study Finds - Pharmacy Practice News
Efficacy of Clotiazepam for Respiratory Dyskinesia in a Patient With Parkinsonism: A Case Report - Cureus
Dental Complications Tardive Dyskinesia Care Insights - Pharmacy Practice News
Tanja Hedberg on sharing her experience of living with primary ciliary dyskinesia (PCD) and recurrent pulmonary infections - European Lung Foundation
Belly Dancer Dyskinesia: A Case Report and Review of Management - Cureus
Cerebral perfusion imaging predicts levodopa-induced dyskinesia in Parkinsonian rat model - Nature
How to Talk About Tardive Dyskinesia with A Doctor - Healthgrades
Haloperidol Induced Orofacial Dyskinesia: Clinical Insights Into Buccolingual Masticatory Syndrome - Wiley Online Library
The Polypharmacy Challenge in Tardive Dyskinesia - Pharmacy Practice News
Brain-region-specific lipid dysregulation in L-DOPA-induced dyskinesia in a primate model of Parkinson’s disease - Nature
Decreased N-acetylaspartate plus N-acetyl-aspartyl-glutamate levels in the caudate of schizophrenia patients with tardive dyskinesia - Nature
Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-1065890 in Adults with Tardive Dyskinesia - PR Newswire
Assessing Tardive Dyskinesia: AIMS and the Clinician’s Tardive Inventory - Pharmacy Practice News
VMAT2 Inhibitors for Tardive Dyskinesia: What Psychiatrists Should Know | Focus - Psychiatry Online
How to Cope With Tardive Dyskinesia Stigma: 6 Tips - Everyday Health
VMAT2 Inhibitor Tardive Dyskinesia Treatment Complexity - Pharmacy Practice News
Austedo Phase 4 Data Shows Reduction in Tardive Dyskinesia Severity - Psychiatric Times
VMAT2 Inhibitor NBI-1065890 Heads to Phase 2 Study in Tardive Dyskinesia - NeurologyLive
Accurate Diagnosis of Tardive Dyskinesia Is Critical to Optimal Outcomes - Pharmacy Practice News
Patient Awareness of Tardive Dyskinesia: Insights From Cherian Karunapuzha, MD - Psychiatric Times
Valbenazine Linked to Better Physical and Emotional Well-Being in Tardive Dyskinesia - NeurologyLive
AI Eyes on TD: Could Video-Based Detection Shrink the Diagnosis Gap? - Pharmacy Practice News
EMA Says Active Substance in Tardive Dyskinesia Drug Not New - Medscape
Improving Early Recognition of Tardive Dyskinesia - Pharmacy Times – Pharmacy Practice News and Expert Insights
A Look At Teva (TEVA) Valuation After New Real World Tardive Dyskinesia Data Release - Yahoo Finance
Teva drafts NFL star Terrell Davis for tardive dyskinesia awareness drive - Fierce Pharma
9 Questions to Ask Your Doctor About Taking VMAT2 Inhibitors for TD - HealthCentral
Tardive Dyskinesia's Impact on Quality of Life - MedPage Today
Neurocrine Biosciences Presents New Post-Hoc Analysis: Treatment with INGREZZA® (valbenazine) Capsules Achieves Earlier Remission of Tardive Dyskinesia Symptoms While Reducing Patient-Reported Disease Burden - PR Newswire
Dyskinesia vs Dystonia: Key Differences Explained - HealthCentral
This condition affects at least 5% of people who take antipsychotic medication - Health: Trusted and Empathetic Health and Wellness Information
Clinical Insights on Dyskinesia and Tremor in Parkinson Disease - NeurologyLive
Neurocrine presents data on tardive dyskinesia treatment - Investing.com
Neurocrine Biosciences Provides Update on Phase 3 Study of Valbenazine in Dyskinetic Cerebral Palsy - PR Newswire
Assessing Neurocrine Biosciences (NBIX) Valuation After New Phase 2 VMAT2 Tardive Dyskinesia Trial Launch - Yahoo Finance
Mitigating the Risk For Tardive Dyskinesia in Elderly Patients on Antipsychotics - MedPage Today
VMAT-2 Inhibitor Differences and Dosing in Tardive Dyskinesia - HMP Global Learning Network
Real-world data shows AUSTEDO improves life for patients with tardive dyskinesia - PharmaTimes
Teva reports diagnostic gap in tardive dyskinesia patients - Investing.com
Teva Kicks Off ‘The Other TD’ to Raise Awareness of Tardive Dyskinesia (TD), with Support from Pro Football Hall of Famer Terrell Davis - Yahoo Finance
Delayed-Release/Extended-Release Amantadine for Dyskinesia and Off Time in Parkinson Disease - NeurologyLive
Acute exacerbation of major depressive disorder following valbenazine treatment for tardive dyskinesia: A case report - Wiley Online Library
A Case of a 66-Year-Old Man With Parkinson Disease and Dyskinesia - NeurologyLive
Primary ciliary dyskinesia (PCD) - genomicsengland.co.uk
Regulating astrocytic activity in the dorsal striatum mitigates L-dopa-induced dyskinesia in Parkinson’s disease - Nature
New data support early use of Ingrezza in mild tardive dyskinesia - The Pharma Letter
Neurocrine's Ingrezza fails phase 3 trial for cerebral palsy - Fierce Pharma
Foreign Language Equivalents
Foreign Language Equivalents of 'dyskinesia'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
dyskiinesia,   dyakinesia,   dyskonesia,   dyskinseia,   ydskinesia,   dysinesia,   dyskinwsia,   dskinesia,   dyskineia,   dyskinesiaa,   dydkinesia,   dyksinesia,   syskinesia,   dyskunesia,   fyskinesia,   dyskniesia,   dysknesia,   dyskinesua,   yskinesia,   dyskinsia,   ddyskinesia,   dyskiensia,   dyskinesiia,   dyskinessia,   dyskineisa,   dyskibesia,   dysskinesia,   dyskinesa,   dsykinesia,   duskinesia,   dyskimesia,   dyskinesai,   dyskinrsia,   dyyskinesia,   dyskinesi,   dyslinesia,   dyskinesis,   dysiknesia,   dyskinnesia,   dtskinesia,   dyskinesoa,   dyskiesia,   dyskineesia,   dyskinedia,   dyskineaia,   dykinesia,   dyskkinesia,   dysjinesia
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z